Global Bladder Cancer Market Size, Share, and COVID-19 Impact Analysis, By Type (Transitional Cell Bladder Cancer, Superficial Bladder Cancer, Invasive Bladder Cancer, Squamous Cell Bladder Cancer, and Others), By Major Tests (Cystoscopy, Biopsy, Urinalysis, Urine Cytology, and Bladder Ultrasound), By Treatment (Surgery, Chemotherapy, Immunotherapy Radiation Therapy, and Others), and by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Feb 2026
REPORT ID SI17473
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Major Test
      3. Market Attractiveness Analysis By Treatment
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increased awareness of bladder risk and the increasing use of the new technologies in diagnostics and treatment
    3. Restraints
      1.  High cost of advanced therapies, limiting patient access, alongside a lack of patient or provider awareness
    4. Opportunities
      1. Development of novel immunotherapies, antibody-drug conjugates (ADCs), and AI-driven diagnostics
    5. Challenges

5.5.1.     High treatment costs, treatment resistance, and limitations in early diagnosis

  1. Global Bladder Cancer Market Analysis and Projection, By Type
    1. Segment Overview
    2. Transitional Cell Bladder Cancer
    3. Superficial Bladder Cancer
    4. Invasive Bladder Cancer
    5. Squamous Cell Bladder Cancer
    6. Others
  2. Global Bladder Cancer Market Analysis and Projection, By Major Test
    1. Segment Overview
    2. Cystoscopy
    3. Biopsy
    4. Urinalysis
    5. Urine Cytology
    6. Bladder Ultrasound
  3. Global Bladder Cancer Market Analysis and Projection, By Treatment
    1. Segment Overview
    2. Surgery
    3. Chemotherapy
    4. Immunotherapy Radiation Therapy
    5. Others
  4. Global Bladder Cancer Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  5. Global Bladder Cancer Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Bladder Cancer Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  6. Company Profiles
    1. AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Pfizer 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Roche 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Merck 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Bristol-Myers Squibb 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Novartis
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   JoEli Lilly
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. GSK
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Sanofi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  UroGen Pharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Astellas Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  2. Global Transitional Cell Bladder Cancer, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  3. Global Superficial Bladder Cancer, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  4. Global Invasive Bladder Cancer, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  5. Global Squamous Cell Bladder Cancer, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  6. Global Others, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  7. Global Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  8. Global Cystoscopy, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  9. Global Biopsy, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  10. Global Urinalysis, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  11. Global Urine Cytology, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  12. Global Bladder Ultrasound, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  13. Global Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  14. Global Surgery, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  15. Global Chemotherapy, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  16. Global Immunotherapy Radiation Therapy, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  17. Global Others, Bladder Cancer Market, By Region, 2024-2035(USD Billion)
  18. North America Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  19. North America Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  20. North America Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  21. U.S.  Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  22. U.S.  Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  23. U.S.  Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  24. Canada Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  25. Canada Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  26. Canada Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  27. Mexico Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  28. Mexico Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  29. Mexico Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  30. Europe Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  31. Europe Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  32. Europe Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  33. Germany Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  34. Germany Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  35. Germany Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  36. France Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  37. France Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  38. France Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  39. U.K.  Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  40. U.K.  Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  41. U.K.  Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  42. Italy Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  43. Italy Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  44. Italy Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  45. Spain Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  46. Spain Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  47. Spain Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  48. Asia Pacific Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  49. Asia Pacific Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  50. Asia Pacific Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  51. Japan Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  52. Japan Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  53. Japan Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  54. China Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  55. China Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  56. China Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  57. India Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  58. India Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  59. India Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  60. South America Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  61. South America Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  62. South America Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  63. Brazil Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  64. Brazil Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  65. Brazil Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  66. The Middle East and Africa Bladder Cancer Market, By Type, 2024-2035(USD   Billion)
  67. The Middle East and Africa Bladder Cancer Market, By Major Test, 2024-2035(USD   Billion)
  68. The Middle East and Africa Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  69. UAE Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  70. UAE Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  71. UAE Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)
  72. South Africa Bladder Cancer Market, By Type, 2024-2035(USD Billion)
  73. South Africa Bladder Cancer Market, By Major Test, 2024-2035(USD Billion)
  74. South Africa Bladder Cancer Market, By Treatment, 2024-2035(USD Billion)

List of Figures 

  1. Global Bladder Cancer Market Segmentation
  2. Bladder Cancer Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Bladder Cancer Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining Power of Buyers
  13. Moderate Bargaining Power of Suppliers
  14. Moderate Bargaining Power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Bladder Cancer Market
  20. Bladder Cancer Market Segmentation, By Type
  21. Bladder Cancer Market For Transitional Cell Bladder Cancer, By Region, 2024-2035 ($ Billion)
  22.  Bladder Cancer Market For Superficial Bladder Cancer, By Region, 2024-2035 ($ Billion)
  23. Bladder Cancer Market For Invasive Bladder Cancer, By Region, 2024-2035 ($ Billion)
  24. Bladder Cancer Market For Squamous Cell Bladder Cancer, By Region, 2024-2035 ($ Billion)
  25. Bladder Cancer Market For Others, By Region, 2024-2035 ($ Billion)
  26.  Bladder Cancer Market Segmentation, By Major Test
  27.  Bladder Cancer Market For Cystoscopy, By Region, 2024-2035 ($ Billion)
  28.  Bladder Cancer Market For Biopsy, By Region, 2024-2035 ($ Billion)
  29. Bladder Cancer Market For Urinalysis, By Region, 2024-2035 ($ Billion)
  30. Bladder Cancer Market For Urine Cytology, By Region, 2024-2035 ($ Billion)
  31. Bladder Cancer Market For Bladder Ultrasound, By Region, 2024-2035 ($ Billion)
  32. Bladder Cancer Market Segmentation, By Treatment
  33. Bladder Cancer Market For Surgery, By Region, 2024-2035 ($ Billion)
  34. Bladder Cancer Market For Chemotherapy, By Region, 2024-2035 ($ Billion)
  35. Bladder Cancer Market For Immunotherapy Radiation Therapy, By Region, 2024-2035 ($ Billion)
  36. Bladder Cancer Market For Others, By Region, 2024-2035 ($ Billion)
  37. AstraZeneca: Net Sales, 2024-2035 ($ Billion)
  38. AstraZeneca: Revenue Share, By Segment, 2024 (%)
  39. AstraZeneca: Revenue Share, By Region, 2024 (%)
  40. Pfizer: Net Sales, 2024-2035 ($ Billion)
  41. Pfizer: Revenue Share, By Segment, 2024 (%)
  42. Pfizer: Revenue Share, By Region, 2024 (%)
  43. Roche: Net Sales, 2024-2035 ($ Billion)
  44. Roche: Revenue Share, By Segment, 2024 (%)
  45. Roche: Revenue Share, By Region, 2024 (%)
  46. Merck: Net Sales, 2024-2035 ($ Billion)
  47. Merck: Revenue Share, By Segment, 2024 (%)
  48. Merck: Revenue Share, By Region, 2024 (%)
  49. Bristol-Myers Squibb: Net Sales, 2024-2035 ($ Billion)
  50. Bristol-Myers Squibb: Revenue Share, By Segment, 2024 (%)
  51. Bristol-Myers Squibb: Revenue Share, By Region, 2024 (%)
  52. Novartis: Net Sales, 2024-2035 ($ Billion)
  53. Novartis: Revenue Share, By Segment, 2024 (%)
  54. Novartis: Revenue Share, By Region, 2024 (%)
  55. JoEli Lilly: Net Sales, 2024-2035 ($ Billion)
  56. JoEli Lilly: Revenue Share, By Segment, 2024 (%)
  57. JoEli Lilly: Revenue Share, By Region, 2024 (%)
  58. GSK: Net Sales, 2024-2035 ($ Billion)
  59. GSK: Revenue Share, By Segment, 2024 (%)
  60. GSK: Revenue Share, By Region, 2024 (%)
  61. Sanofi.: Net Sales, 2024-2035 ($ Billion)
  62. Sanofi.: Revenue Share, By Segment, 2024 (%)
  63. Sanofi.: Revenue Share, By Region, 2024 (%)
  64. UroGen Pharma: Net Sales, 2024-2035 ($ Billion)
  65. UroGen Pharma: Revenue Share, By Segment, 2024 (%)
  66. UroGen Pharma: Revenue Share, By Region, 2024 (%)
  67. Astellas Pharma: Net Sales, 2024-2035 ($ Billion)
  68. Astellas Pharma: Revenue Share, By Segment, 2024 (%)
  69. Astellas Pharma: Revenue Share, By Region, 2024 (%)
  70. Others: Net Sales, 2024-2035 ($ Billion)
  71. Others: Revenue Share, By Segment, 2024 (%)
  72. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:120
Pages:240
Countries covered:17
Companies covered::20
Forecast CAGR:CAGR of 12.64%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies